TrialA Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease
Trial details
- Registry ID
- NCT05642442
- Phase
- Phase 2
Drug research
Suvecaltamide
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as CX-8998; JZP385; MK-8998
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's DiseaseNCT05642442 | Jazz Pharmaceuticals | Phase 2 | Completed | 2024-10-23Actual |
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |